PALLIATIVE TREATMENT OF PAINFUL BONE METASTASES
Requisition Forms

Strontium-89 therapy and Samarium-153 therapy

Procedure description:

Sr-89 chloride and Sm-153 lexidronam are indicated for the treatment of bone pain resulting from a metastatic malignancy that has involved multiple skeletal sites and has evoked an osteoblastic response on bone scintigraphy.